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Abstract
Background: Pathological diagnosis of urothelial carcinoma (UC) is primarily based on cytological atypia. It has
previously been shown that high-grade (HG) UC, particularly UC in situ cells (CIS), can be over five times the size of
a lymphocyte. However, this has not been demonstrated in comparison to reactive urothelium. The objective of
this study was to empirically compare the difference in nuclear size of UC cells with reactive urothelial cells.
Methods: Using CellSens imaging software, we measured urothelial nuclear length (l) and width (w) on digital
images of H&E sections. The area (a) of a nucleus was calculated based on the oval shape of most urothelial cells.
Lymphocytes were measured to calculate normalized urothelial linear and area ratios.
Results: A total of 1085 urothelial cell nuclei from 60 cases were measured from reactive urothelium, low grade
(LG) UC, HG UC and CIS. CIS nuclei were found to have an a 2.75 times larger than reactive nuclei (p < 0.001). A
nuclear size cut-off of 11 um for l and 7 um for w was found to be sensitive [98.09 % (95 % CI: 95.60–99.38 %) and
89.31 % (95 % CI: 83.6–91.82 %) for l and w, respectively] and specific [92.60 % (95 % CI: 87.13–95.82 %) and 85.71 %
(95 % CI: 79.49–90.63 %) for l and w, respectively] for distinguishing CIS from reactive atypia.
Conclusions: Nuclear morphometry can be used to differentiate CIS from reactive atypia. A l over 11 um and a w
over 7 um and is highly sensitive and specific for CIS compared to reactive urothelium. This difference in nuclear
size may be used as a tool for differentiating the flat urothelial lesions from reactive urothelium in daily practice.
Keywords: Nucleomegaly, Reactive urothelial atypia, Urothelial carcinoma in situ (CIS), High-grade urothelial
carcinoma (HG UC), Low-grade urothelial carcinoma (LG UC)
Background
Urothelial carcinomas (UC) including papillary tumors
and flat urothelial carcinoma in situ (CIS) are diagnosed
primarily based on cytological atypia with or without
papillary configuation. Much attention has been focused
on the morphology of urothelial papillary lesions while
less clear morphologic criteria apply to the flat urothelial
lesion of CIS and its progression to invasive UC. Urothe-
lial CIS is a particularly important diagnosis because it is
the precursor lesion to invasive UC, with high-grade
cytologic atypia that may be more pronounced than in-
vasive UC.
One helpful feature for detecting cytologic atypia is
nucleomegaly of urothelial cells. Because of the lack of
reliable reference urothelial cells in tissue sections, lym-
phocytes are often used for comparison. It has been pro-
posed that the mean nuclear area of urothelium relative to
lymphocytes is the best way to discriminate cytologically
malignant urothelium from benign urothelium [1]. CIS
nuclei have been shown to be approximately five times lar-
ger than a lymphocyte and 1.5 times larger than dysplastic
urothelial nuclei whereas reactive urothelial nuclei and
lower-grade dysplastic nuclei are approximately twice the
size of a lymphocyte [1]. However, it remains unknown
what the size difference is to distinguish reactive urothe-
lium from CIS.
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Modern technology has afforded use widely available
software to practicing pathologists to make objective
measurements to quickly differentiate between high-
grade dysplasia and reactive atypia. Digital images of the
bladder urothelium can be analyzed on high-power to
look at a variety of parameters, including nuclear length
(l), width (w) and area (a). However, it currently remains
unknown what numerical criteria should be applied to
distinguish dysplasia from benignancy.
Methods
The Northwestern Memorial Hospital (Chicago, IL)
pathology database was searched for random, noncon-
secutive patients over the period of April 2014 to April
2015 who had a biopsy- or surgical-resection diagnosis
by a genitourinary specialty pathologist (X.Y.) of reactive
urothelium, low grade UC (LG UC) and high grade
UC (HG UC) and urothelial CIS (WHO, 2004). Research
involving human data was in accordance with the ethical
standards of the Northwestern University Institutional
Review Board (IRB). Formalin-fixed and paraffin-embedded
hematoxylin and eosin (H&E)-stained bladder and ureter
biopsies and surgical resection slides were obtained from
60 cases including 10 cases of reactive urothelium, 20 cases
of LG UC, 20 cases of HG UC, and 10 cases of urothelial
CIS (see Fig. 1a-d).
Using a Nikon digital microscope equipped with a 40x
objective and the imaging software Olympus CellSens
(CellSens,Version 510_UMA_cellSens17-Indus-en_00), l
and w of nuclei were measured on up to five captured
images and reviewed blindly by genitourinary pathology
specialists (see Fig. 2a-b). For each case, a minimum of
ten nuclei per 40x field (0.196 mm2) totaling a minimum
of 20 nuclei were measured. Among pleomorphic
urothelial nuclei, the largest nuclei in each field were se-
lected for measurement. Umbrella cells were excluded
from measurement. Lymphocytes on corresponding sec-
tions were measured in two dimensions that were then
averaged, to be used as the reference standard. Snap-
shots of each field including a raw version without listed
nuclear measurements were saved as jpeg files and
measurements were extracted into excel for data analysis
in order to calculate a and size ratios with reference
lymphocyte. This was calculated by dividing the average
urothelial nuclear l, w and a by the average lymphocyte
l and a.
Statistical analysis
Statistical significance within each of the urothelial four
groups (reactive urothelium, LG UC, HG UC and CIS)
was determined by calculation of the standard deviation
(SD) from the mean nuclear l, w and a as well as the
95 % confidence interval (CI). Statistically significant dif-
ferences in nuclear l, w and A between two groups were
calculated with a Student’s T test and amongst all groups
with a one-way ANOVA. Nuclear size cut-offs for strati-
fication of reactive nuclei from CIS were determined
based on calculation of a nuclear l and w cut-off with a
sensitivity and specificity and 95 % CI’s obtained via a
ROC-curve analysis. Statistical power was calculated for
comparison of reactive nuclei and CIS as a one-tail test
with corresponding standard deviations and using an
alpha error level of 5 %.
Results
We measured 1085 nuclei, including 32 from lympho-
cytes, 168 from reactive urothelium, 271 from LG UC,
384 from HG UC and 262 from urothelial CIS (see
Table 1). The mean l, w and a per category increased
linearly according to degree of dysplasia and with a tight
SD and 95 % CI (see Fig. 3).
I. Differences in nuclear length and width
Using ANOVA for intergroup comparisons, all
categories were statistically significant from one
another for l and w measurement comparisons. The
mean nuclear l for each category was measured as
follows: reactive urothelium, 8.91 um [SD: 1.95,
95 % CI (8.62, 9.2)]; LG UC, 10.85 um [SD: 1.82,
95 % CI (10.63, 11.07)], HG UC, 13.56 um [SD: 3.52,
95 % CI (13.21, 13.91)]; CIS, 15.17 um [SD: 3.03,
95 % CI (14.8, 15.54)]. In comparison to the
Fig. 1 Reactive and Neoplastic Urothelium Categories Photomicrographs Taken With CellSens at 40x. a Reactive urothelium b LG UC c LG UC d CIS
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reference lymphocyte, which was circular-shaped
and had both an average l and w of 4.81 um, nuclei
from HG UC and CIS had l size ratios as follows:
reactive urothelium, 1.85 (P < 0.001); LG UC, 2.26
longer (P < 0.001); HG UC, 2.82 times longer
(P < 0.001); CIS, 3.15 (P < 0.001). Similarly, the
mean nuclear w increased linearly according to
nuclear grade as follows: reactive urothelium, 5.75
um [SD: 1.29, 95 % CI (5.55, 5.95)]; LG UC, 6.92
[SD: 1.2, 95 % CI (6.78, 7.06)]; HG UC, 8.92 [SD:
2.54, 95 % CI (8.57, 9.07)]; CIS, 9.35 um [SD:
2.22, 95 % CI (9.08, 9.62)]. Size ratios for nuclear
w were as follows: reactive urothelium, 1.2
(P < 0.001); LG UC, 1.44 (P < 0.001); HG UC,
1.83 (P < 0.001); CIS, 1.94 (P < 0.001).
The greatest difference in nuclear l and w were
consistently observed between reactive urothelium
nuclei and CIS nuclei—CIS nuclei were 1.70 times
longer and 1.55 times wider than nuclei of reactive
urothelium. This difference was less for dysplastic
nuclei of UC compared to reactive lymphocytes.
Measured nuclei of HG UC were only1.52 times
longer and 1.53 times wider than measured nuclei of
reactive urothelium. HG UC had the greatest w
compared to all other categories, and this was over
twice as large as the w for LG UC. CIS nuclei were
Fig. 2 Measuring Nuclei of HGUC and CIS. a Example of high-power (40x) photomicrograph of HG UC taken for nuclear size measurements.
b Representative schematic of CellSens software to measure nuclear l and w, in a case of urothelial CIS





L um SD 95 % CI W
um
SD 95 % CI Area
um2








10 168 8.91 1.95 [8.62, 9.2] 5.75 1.29 [5.55, 5.95] 42.03 16.50 [39.5, 44.5] 1.85, 1.2 2.32
LG UCa 20 271 10.85 1.82 [10.63, 11.07] 6.92 1.20 [6.78, 7.06] 60.46 17.68 [58.36, 62.56] 2.26, 1.44 3.33
HG UCa 20 384 13.56 3.52 [13.21, 13.91] 8.82 2.54 [8.57, 9.07] 100.24 68.15 [93.42, 107.06] 2.82, 1.83 5.53
CIS 10 262 15.17 3.03 [14.8, 15.54] 9.35 2.22 [9.08, 9.62] 115.5 45.3 [110.01, 120.99] 3.15, 1.94 6.37
LG UC low-grade urothelial carcinoma, HG UC high-grade urothelial carcinoma, CIS carcinoma in situ, SD standard deviation, CI confidence interval, l length,
w width, a area
aMean l and w (um) of lymphocyte = 4.81
bMean a (um2) of lymphocyte = 18.12
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both longer and wider than low and high-grade
dysplastic nuclei of UC.
II. Differences in nuclear area
Similar to nuclear l and w, the a of LG UC, HG UC
and CIS nuclei increased linearly in comparison to
both the reference lymphocyte and reactive
urothelial nuclei. However, sizes were polarized
based on group—LG UC had an a closer in value to
reactive urothelium whereas HG UC and CIS nuclei
were of comparable sizes (see Fig. 4). The measured
a were as follows: reactive urothelium, 42.03 um2
[SD: 16.5, 95 % CI (39.5, 44.5)]; LG UC, 60.46 um2
[SD: 17.68, 95 % CI (58.36, 62.56)]; HG UC, 100.24
um2 [SD: 68.15, 95 % CI (93.42, 107.06)]; CIS, 115.5
um2 [SD: 115.5, 95 % CI (110.01, 120.99)]. Size
ratios with the reference lymphocyte were greatest
for HG UC and CIS nuclei and were calculated for
all groups as follows: reactive urothelium, 2.32
(P < 0.001); LG UC, 3.33 (P < 0.001); HG UC, 5.53
(P < 0.001); CIS, 6.37 times larger (P < 0.001).
Similarly, nuclei of HG UC and CIS had the greatest
difference in a when compared with reactive
urothelium and were 2.75 um2 and 2.38 um2 times
larger (P < 0.001). This size difference was
considerably smaller (1.43 um2) when comparing
LG UC with reactive urothelium (P < 0.001).
III.Nuclear size stratification system to differentiate
reactive urothelium from CIS
Fig. 3 Comparison of Nuclear Length and Width Among Different Groups of Urothelium. Comparison of nuclear l and w of reactive urothelium
(diamond), LG UC (square), HG UC (triangle) and CIS (circle). Trend line shows w and l increase linearly according to nuclear grade of dysplasia
Fig. 4 Comparison of Areas Among Reactive and Neoplastic Nuclei. Comparison of nuclear a for reactive urothelial, LG UC, HG UC and CIS
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Of most clinical interest is distinguishing CIS from
reactive atypia, for which in our case the differences
in l and w between these two groups each had
statistical powers of 100 %. Based on the largest size
differentials in l, w and a between reactive urothelium
and CIS, nuclear cut off points were devised to
separate approximately 95 % of CIS nuclei from
reactive urothelium nuclei. A nuclear size cut-off of
11 um for l and 7 um for w was found to be sensitive
[98.09 % (95 % CI: 95.60–99.38 %) and 89.31 %
(95 % CI: 83.6–91.82 %) for l and w, respectively]
and specific [92.60 % (95 % CI: 87.13–95.82 %) and
85.71 % (95 % CI: 79.49–90.63 %) for l and w,
respectively] for distinguishing CIS from reactive
atypia. Similarly, a nuclear a of 65.45 um2 stratifies
95 % of CIS nuclei from reactive urothelium
nuclei. For this reason, we prefer a nuclear l and
w stratification system of 11 um and 7 um,
respectively, for reliably detecting CIS and
minimizing the likelihood that a reactive urothelial cell
is mistaken as CIS (see Fig. 5). The sensitivity of
using this length cut off for l is 98.09 %, 95 % CI
[0.84–0.92]. The specificity of this l cut-off is
0.92, 95 % CI [0.87–0.92] and w cut-off is 0.86,
95 % CI [0.79, 0.90].
Discussion
In this study, we have shown using the nuclear length and
width on a conventional digital camera can be very helpful
to distinguish benign and high grade urothelial carcinoma,
particularly useful for differentiating the diagnostically
challenging cases of reactive atypical urothelium from
CIS. Perhaps one of the most diagnostically challenging
dilemmas is distinguishing CIS from reactive urothelial
aytpia when no other urothelial abnormalities are present.
While stage is the most important prognostic indica-
tor of long-term prognosis, grade is important at the
time of biopsy of urothelial lesions for determining
risk of progression and association with invasive disease2.
According to the TNM (tumor, node, metastasis) staging
system, high-grade cytology is seen in 90 % of superficial
urothelial neoplasms (Ta and T1) with invasion confined
to the lamina propria [2].
In normal urothelium, there are basal, intermediate
and superficial umbrella cells that span three to seven
layers based on the state of bladder distension [2]. Com-
pared to the hyperchromatic nuclei of the basal cells, the
intermediate cells have round-to-oval shaped nuclei that
often include grooves and have clear or amphophilic
cytomplasm. Overlying these intermediate cells is the
superficial layer coined umbrella cells, which have vari-
ably sized nuclei and voluminous eosinophilic cytoplasm.
Urothelium may show varying degrees of architectural
distortion and loss of polarity of these cell layers without
becoming dysplastic [2].
Flat urothelial lesions of CIS are hallmarked by the
partial or full-thickness involvement of the urothelium
by cytologically atypical cells. It can diffusely involve the
surface of the bladder and is usually treated intravesically
with Bacillus Calmette-Guerin (BCG). In other clinical
scenarios, pagetoid CIS may only present as a few neo-
plastic cells with enlarged nuclei scattered throughout an
otherwise orderly arranged urothelium [2]. While nucleo-
megaly is one of the key features of cytologic atypical in
UC, it can also be seen in reactive urothelium [3–6]. It is
prudent to first analyze urothelium at the10x objective
lens because CIS can typically be distinguished from react-
ive urothelium based on the presence of pleomorphic cells
with enlarged, hyperchromatic nuclei compared to the
monotonous enlarged nuclei of reactive urothelium [3].
Fig. 5 Comparison of Nuclear Cell Length and Width for Reactive Urothelium and CIS. A cut-off nuclear l of 11 um and nuclear w of 7 um
(solid lines) differentiates CIS nuclei (circles) from reactive urothelial nuclei (diamonds)
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Confirmation at a higher-power field can be made in rela-
tion to adjacent lymphocytes. CIS nuclei more commonly
show central clearing with eccentrically-placed nucleoli
whereas nuclei of reactive urothelium have vesicular
chromatin with centrally-placed nucleoli [1, 3, 5, 7, 8].
Both entities may have mitotic figures, however in benign
reactive conditions these are more commonly located in
the rapidly dividing basal cell layer. In some cases, the
morphologic differentiation between reactive atypia and
dysplasia is subtle with the only difference being the de-
gree of nuclear enlargement.
The diagnosis of invasive UC is based on histologic
evidence of invasion of neoplastic cells into the under-
lying lamina propria. According to the World Health
Organization (WHO) 2003/International Society of Uro-
logical Pathologists [WHO(2003)/ISUP] classification,
invasive UC is graded according to a two-tier system de-
fined as high-grade (HG) and low-grade (LG) [3]. LG
UC is less common and may be seen in the nested UC
variant where it can be overlooked due to its deceptively
bland cytology [2]. Cytologic features of LG UC include
more subtle variations in nuclear size, shape and chroma-
tin texture and loss of nuclear polarity [2]. While infre-
quent and typically located in the lower-half of the
urothelium, mitotic figures may also be seen at higher
levels of the urothelium. In comparison, features that
characterize HG UC include disorganized epithelium with
more frequent mitoses, clumped chromatin, prominent
nucleoli and importantly, nucleomegaly.
To date, this is the first study to systematically evaluate
the specific difference in nuclear size amongst categories
of benign and dysplastic urothelium in a large cohort of
patients. We determined ratios for nuclear size in refer-
ence to the l and w of lymphocytes as a way to standardize
the data (see Fig. 5) and to determine whether a size
criteria can be applied to differentiate CIS from reactive
atypia. We show that nuclei that are over 11 um and 7 um
in l and w, respectively, are most likely CIS in the absence
of a HG infiltrative lesion. This size cut-off was deter-
mined with simple microscopy tools available that are in
most clinical settings. Using this size cut-off to diagnose
CIS has a sensitivity of 98.09 and 89.31 % for l and w
respectively, with fairly high specificities of 86.90 and
85.71 % for l and w, respectively. While the optimal
size criteria would have higher specificities without
lowering the sensitivity, in this case choosing a higher
specificity would substantially decrease the sensitivity
and likely result in a risky number of false negative
CIS cases. While the risk of false positives with this
case cannot be excluded based on the considerably
higher l sensitivity compared to specificity, it is im-
portant to remember that these cut-offs are first and
foremost devised as a screening technique for CIS,
particularly in the case of small biopsies where erring
on the conservative side could result in long-term conse-
quences of high-grade malignancy.
We found that among CIS nuclei (n = 262) selected
from resection and TURBT specimens, CIS nuclei
have a mean area that exceeds previous estimates and
were approximately 6.37 times larger than a lymphocyte
(P < 0.001). Additionally, we found that CIS nuclei are ap-
proximately 2.75 times larger in a compared to reactive
urothelium. We also show that CIS is a lesion with even
greater nucleomegaly compared to its invasive LG and
HG UC counterparts when using a l, w, and a nuclear size
comparison. CIS nuclei are closer in size to HG UC nuclei
versus LG UC and reactive urothelium nuclei in both l
and w. This confirms that LG UC is a lesion of low cyto-
logic atypia when using nucleomegaly as a sole measuring
criterion and that LG UC is difficult to distinguish from
reactive urothelial atypia because of their morphologic
resemblance.
Some of the limitations of this study include the diffi-
culty in distinguishing LG UC from reactive urothelial cell
when papillary architecture commonly seen in LG UC is
absent. Additional limitations include not accounting for
whether CIS lesions analyzed in this study are part of a
HG UC process that was not picked up on biopsy speci-
mens. Additionally, this study could benefit from the in-
clusion of UC cases arising outside the bladder or ureter,
such as the renal pelvis.
By accounting for cases of CIS in both the urinary blad-
der and ureters, it is the intent of this study to present
practicing pathologists with a simple size-criterion to diag-
nose what is otherwise thought to be a widely underdiag-
nosed entity in the common scenarios of focal CIS
involvement and thinned-out urothelium that presents as
‘clinging’ CIS.
Conclusions
In this study we found that nuclear morphometry can be
used to differentiate CIS from reactive atypia—a particu-
larly challenging clinical scenario that can present in time-
sensitive instances where nuclear features are often the
only sign of atypia, such as at frozen section for establish-
ing clean margins for bladder resection specimens. More
specifically, by analyzing 1085 nuclei including from lym-
phocytes, reactive urothelium, LG UC, HG UC and
urothelial CIS, we find that the mean l, w and a per cat-
egory increased linearly according to degree of dysplasia
and with a tight SD and 95 % CI. For the first time we es-
tablish stringent criteria and guidelines for differentiating
reactive urothelial nuclei from those of urothelial CIS with
high specificity and sensitivity: a l over 11 um and a w over
7 um are accurate cut-offs for distinguishing the former
from the latter. This difference in nuclear size may be
used as a tool for differentiating the flat urothelial lesions
from reactive urothelium in daily practice.
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a, area; CI, confidence interval; CIS, carcinoma in situ; HG UC, high-grade
urothelial carcinoma (HG UC); l, length; LG UC, low-grade urothelial
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